Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Lue

Showing results (131-140 of 137) with videos related to

Pageof 14
Sort By:
You have reached the last page of results.This site can display upto 137 results.
Acta Geneticae Medicae Et Gemellologiae|January 1, 1990
Chronological changes in genetic variance and heritability of systolic and diastolic blood pressure among Chinese twin neonatesM W Yu, C J Chen, C J Wang, et al.
Journal of Glaucoma|January 1, 1992
A comparison of the ocular hypotensive efficacy of twice-daily 0.25% levobunolol to 0.5% timolol in patients previously treated with 0.5% timololC C Beehler, W C Stewart, D K Macdonald, et al.
The American Journal of Cardiology|May 20, 1998
Usefulness of electron beam computed tomography in children with heterotaxy syndromeS J Chen, Y W Li, J K Wang, et al.
Cutis|July 2, 1999
Tazarotene gel is safe and effective in the treatment of acne vulgaris: a multicenter, double-blind, vehicle-controlled studyA R Shalita, D K Chalker, R F Griffith, et al.
Journal of the American Academy of Dermatology|October 20, 1998
Tazarotene 0.1% gel plus corticosteroid cream in the treatment of plaque psoriasisM G Lebwohl, D L Breneman, B S Goffe, et al.
Journal of the American Academy of Dermatology|July 1, 1997
Tazarotene gel, a new retinoid, for topical therapy of psoriasis: vehicle-controlled study of safety, efficacy, and duration of therapeutic effectG D Weinstein, G G Krueger, N J Lowe, et al.
Journal of the American Academy of Dermatology|May 20, 1998
Once-daily tazarotene gel versus twice-daily fluocinonide cream in the treatment of plaque psoriasisM Lebwohl, E Ast, J P Callen, et al.
Pageof 14

Showing results (131-140 of 137) with videos related to

Sort By:
Pageof 14
You have reached the last page of results.This site can display upto 137 results.
Acta Geneticae Medicae Et Gemellologiae|January 1, 1990
Chronological changes in genetic variance and heritability of systolic and diastolic blood pressure among Chinese twin neonatesM W Yu, C J Chen, C J Wang, et al.
Journal of Glaucoma|January 1, 1992
A comparison of the ocular hypotensive efficacy of twice-daily 0.25% levobunolol to 0.5% timolol in patients previously treated with 0.5% timololC C Beehler, W C Stewart, D K Macdonald, et al.
The American Journal of Cardiology|May 20, 1998
Usefulness of electron beam computed tomography in children with heterotaxy syndromeS J Chen, Y W Li, J K Wang, et al.
Cutis|July 2, 1999
Tazarotene gel is safe and effective in the treatment of acne vulgaris: a multicenter, double-blind, vehicle-controlled studyA R Shalita, D K Chalker, R F Griffith, et al.
Journal of the American Academy of Dermatology|October 20, 1998
Tazarotene 0.1% gel plus corticosteroid cream in the treatment of plaque psoriasisM G Lebwohl, D L Breneman, B S Goffe, et al.
Journal of the American Academy of Dermatology|July 1, 1997
Tazarotene gel, a new retinoid, for topical therapy of psoriasis: vehicle-controlled study of safety, efficacy, and duration of therapeutic effectG D Weinstein, G G Krueger, N J Lowe, et al.
Journal of the American Academy of Dermatology|May 20, 1998
Once-daily tazarotene gel versus twice-daily fluocinonide cream in the treatment of plaque psoriasisM Lebwohl, E Ast, J P Callen, et al.
Pageof 14